Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015:2015:878517.
doi: 10.1155/2015/878517. Epub 2015 Jul 12.

Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back

Affiliations
Clinical Trial

Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back

Sanjay K Agarwal et al. Biomed Res Int. 2015.

Abstract

The purpose of this study was to assess the impact of 3 months of aromatase inhibition together with progestin add-back on ovarian endometrioma size. This prospective cohort study was performed at University Medical Center (UC San Diego). Women trying to conceive were excluded. After informed consent, all women were treated with the aromatase inhibitor letrozole (5 mg/d) with norethindrone acetate (5 mg/d) add-back for 3 months. Pre- and posttreatment assessments of endometrioma sizes were performed by ultrasound. The impact of treatment on pain was determined using the patient assessed endpoints of the Biberoglu and Behrman scale. These included assessing dysmenorrhea, dyspareunia, and nonmenstrual pelvic pain each on a scale from 0 to 3. The primary endpoint of this study was the change in ultrasound documented endometrioma size. Fourteen endometriomas in 8 consecutive women were treated for 3 m. Mean endometrioma diameter decreased 50% from 4.6 ± 1.6 cm to 2.3 ± 1.6 cm (mean ± SD). This represents a 75% decrease in endometrioma volume. Endometriosis symptoms of dysmenorrhea, dyspareunia, and nonmenstrual pelvic pain also improved with treatment. In conclusion, a 3-month course of high dose aromatase inhibition with progestin add-back significantly reduces ovarian endometrioma size and warrants further investigation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of endometrioma diameter quartiles prior to and after treatment with 3 months of aromatase inhibition plus progestin add-back.
Figure 2
Figure 2
Change in individual endometrioma volumes. Mean endometrioma volume decreased 75% from 60.1 cm3 to 15.0 cm3 with 3 months of aromatase inhibition plus progestin add-back.

References

    1. Ferrero S., Venturini P. L., Gillott D. J., Remorgida V., Leone Roberti Maggiore U. Hemostasis by bipolar coagulation versus suture after surgical stripping of bilateral ovarian endometriomas: a randomized controlled trial. Journal of Minimally Invasive Gynecology. 2012;19(6):722–730. doi: 10.1016/j.jmig.2012.08.001. - DOI - PubMed
    1. Celik H. G., Dogan E., Okyay E., et al. Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimüllerian hormone levels. Fertility and Sterility. 2012;97(6):1472–1478. doi: 10.1016/j.fertnstert.2012.03.027. - DOI - PubMed
    1. Var T., Batioglu S., Tonguc E., Kahyaoglu I. The effect of laparoscopic ovarian cystectomy versus coagulation in bilateral endometriomas on ovarian reserve as determined by antral follicle count and ovarian volume: a prospective randomized study. Fertility and Sterility. 2011;95(7):2247–2250. doi: 10.1016/j.fertnstert.2011.03.078. - DOI - PubMed
    1. Almog B., Sheizaf B., Shalom-Paz E., Shehata F., Al-Talib A., Tulandi T. Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilization. Fertility and Sterility. 2010;94(6):2340–2342. doi: 10.1016/j.fertnstert.2010.01.055. - DOI - PubMed
    1. Younis J. S., Ezra Y., Laufer N., Ohel G. Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata. Journal of Assisted Reproduction and Genetics. 1997;14(6):343–346. doi: 10.1007/BF02765839. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources